488 related articles for article (PubMed ID: 21824920)
1. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.
Egan BM; Zhao Y; Axon RN; Brzezinski WA; Ferdinand KC
Circulation; 2011 Aug; 124(9):1046-58. PubMed ID: 21824920
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
Egan BM; Zhao Y; Li J; Brzezinski WA; Todoran TM; Brook RD; Calhoun DA
Hypertension; 2013 Oct; 62(4):691-7. PubMed ID: 23918752
[TBL] [Abstract][Full Text] [Related]
3. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES).
Kaczmarski KR; Sozio SM; Chen J; Sang Y; Shafi T
BMC Nephrol; 2019 Apr; 20(1):138. PubMed ID: 31023262
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
Chen J; Bundy JD; Hamm LL; Hsu CY; Lash J; Miller ER; Thomas G; Cohen DL; Weir MR; Raj DS; Chen HY; Xie D; Rao P; Wright JT; Rahman M; He J
Hypertension; 2019 Apr; 73(4):785-793. PubMed ID: 30776971
[TBL] [Abstract][Full Text] [Related]
5. Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40-69 year olds.
Petersen J; Malyutina S; Ryabikov A; Kontsevaya A; Kudryavtsev AV; Eggen AE; McKee M; Cook S; Hopstock LA; Schirmer H; Leon DA
BMC Cardiovasc Disord; 2020 Mar; 20(1):135. PubMed ID: 32169049
[TBL] [Abstract][Full Text] [Related]
6. Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
Bakris G; Chen C; Campbell AK; Ashton V; Haskell L; Singhal M
Am J Hypertens; 2024 May; 37(6):438-446. PubMed ID: 38436491
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
Carey RM; Sakhuja S; Calhoun DA; Whelton PK; Muntner P
Hypertension; 2019 Feb; 73(2):424-431. PubMed ID: 30580690
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
Thomas G; Xie D; Chen HY; Anderson AH; Appel LJ; Bodana S; Brecklin CS; Drawz P; Flack JM; Miller ER; Steigerwalt SP; Townsend RR; Weir MR; Wright JT; Rahman M;
Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
[TBL] [Abstract][Full Text] [Related]
9. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
[TBL] [Abstract][Full Text] [Related]
10. Health care fragmentation and blood pressure control among adults taking antihypertensive medication.
Colvin CL; Safford MM; Muntner P; Colantonio LD; Kern LM
Am J Manag Care; 2022 Mar; 28(3):108-115. PubMed ID: 35404546
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
de Beus E; Bots ML; van Zuilen AD; Wetzels JF; Blankestijn PJ;
Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024
[TBL] [Abstract][Full Text] [Related]
12. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
Irvin MR; Booth JN; Shimbo D; Lackland DT; Oparil S; Howard G; Safford MM; Muntner P; Calhoun DA
J Am Soc Hypertens; 2014 Jun; 8(6):405-13. PubMed ID: 24952653
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
Akinyelure OP; Sakhuja S; Colvin CL; Clark D; Jaeger BC; Hardy ST; Howard G; Cohen LP; Irvin MR; Tanner R; Carey RM; Muntner P
Hypertension; 2020 Dec; 76(6):1953-1961. PubMed ID: 33131312
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.
de Beus E; van der Sande NGC; Bots ML; Spiering W; Voskuil M; Visseren FLJ; Blankestijn PJ
BMJ Open; 2017 Sep; 7(9):e016692. PubMed ID: 28882918
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and factors associated with resistant hypertension in a large health maintenance organization in Israel.
Weitzman D; Chodick G; Shalev V; Grossman C; Grossman E
Hypertension; 2014 Sep; 64(3):501-7. PubMed ID: 24958503
[TBL] [Abstract][Full Text] [Related]
16. Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension.
Egan BM; Kai B; Wagner CS; Henderson JH; Chandler AH; Sinopoli A
J Clin Hypertens (Greenwich); 2016 Aug; 18(8):817-24. PubMed ID: 26856795
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.
Mielke J; Trucks-Jansen H; Schurmann C; Kotsis F; Köttgen A; Schneider MP; Eckardt KU; ; Freitag DF; Eitner F; Becker MS
J Hum Hypertens; 2023 May; 37(5):345-353. PubMed ID: 35534618
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of resistant hypertension in the United States, 2003-2008.
Persell SD
Hypertension; 2011 Jun; 57(6):1076-80. PubMed ID: 21502568
[TBL] [Abstract][Full Text] [Related]
20. Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods.
Bakris G; Lin PP; Xu C; Chen C; Ashton V; Singhal M
J Clin Hypertens (Greenwich); 2024 May; 26(5):500-513. PubMed ID: 38523465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
